vs

Side-by-side financial comparison of Ardent Health, Inc. (ARDT) and Eastman Chemical Company (EMN). Click either name above to swap in a different company.

Eastman Chemical Company is the larger business by last-quarter revenue ($2.0B vs $1.6B, roughly 1.2× Ardent Health, Inc.). Eastman Chemical Company runs the higher net margin — 5.3% vs 2.8%, a 2.5% gap on every dollar of revenue.

Goodlife Health Clubs is a chain of health clubs, with more than 80 locations in Australia.

Eastman Chemical Company is an American chemical products manufacturer based in Kingsport, Tennessee. Founded in 1920, it was formerly a subsidiary of Kodak until 1994. The company is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. It operates 36 manufacturing sites worldwide and employs approximately 14,000 people. In 2023, Eastman had sales revenue of approximately $9.21 billion.

ARDT vs EMN — Head-to-Head

Bigger by revenue
EMN
EMN
1.2× larger
EMN
$2.0B
$1.6B
ARDT
Higher net margin
EMN
EMN
2.5% more per $
EMN
5.3%
2.8%
ARDT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ARDT
ARDT
EMN
EMN
Revenue
$1.6B
$2.0B
Net Profit
$45.0M
$105.0M
Gross Margin
17.1%
Operating Margin
5.8%
Net Margin
2.8%
5.3%
Revenue YoY
-13.8%
Net Profit YoY
-42.3%
EPS (diluted)
$0.32
$0.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARDT
ARDT
EMN
EMN
Q1 26
$2.0B
Q4 25
$1.6B
$2.0B
Q3 25
$1.6B
$2.2B
Q2 25
$1.6B
$2.3B
Q1 25
$1.5B
$2.3B
Q4 24
$2.2B
Q3 24
$1.4B
$2.5B
Q2 24
$1.5B
$2.4B
Net Profit
ARDT
ARDT
EMN
EMN
Q1 26
$105.0M
Q4 25
$45.0M
$105.0M
Q3 25
$-23.5M
$47.0M
Q2 25
$73.0M
$140.0M
Q1 25
$41.4M
$182.0M
Q4 24
$330.0M
Q3 24
$26.3M
$180.0M
Q2 24
$42.8M
$230.0M
Gross Margin
ARDT
ARDT
EMN
EMN
Q1 26
17.1%
Q4 25
17.1%
Q3 25
19.7%
Q2 25
22.1%
Q1 25
24.8%
Q4 24
24.7%
Q3 24
24.6%
Q2 24
25.3%
Operating Margin
ARDT
ARDT
EMN
EMN
Q1 26
Q4 25
5.8%
0.6%
Q3 25
-0.1%
6.1%
Q2 25
7.4%
7.4%
Q1 25
5.0%
11.0%
Q4 24
13.2%
Q3 24
3.9%
11.4%
Q2 24
5.6%
12.1%
Net Margin
ARDT
ARDT
EMN
EMN
Q1 26
5.3%
Q4 25
2.8%
5.3%
Q3 25
-1.5%
2.1%
Q2 25
4.4%
6.1%
Q1 25
2.8%
7.9%
Q4 24
14.7%
Q3 24
1.8%
7.3%
Q2 24
2.9%
9.7%
EPS (diluted)
ARDT
ARDT
EMN
EMN
Q1 26
$0.93
Q4 25
$0.32
$0.93
Q3 25
$-0.17
$0.40
Q2 25
$0.52
$1.20
Q1 25
$0.29
$1.57
Q4 24
$2.81
Q3 24
$0.19
$1.53
Q2 24
$0.34
$1.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARDT
ARDT
EMN
EMN
Cash + ST InvestmentsLiquidity on hand
$709.6M
$566.0M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$1.3B
$6.0B
Total Assets
$5.3B
$14.9B
Debt / EquityLower = less leverage
0.84×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARDT
ARDT
EMN
EMN
Q1 26
$566.0M
Q4 25
$709.6M
$566.0M
Q3 25
$609.4M
Q2 25
$540.6M
Q1 25
$495.0M
Q4 24
$837.0M
Q3 24
$563.1M
Q2 24
$334.5M
Total Debt
ARDT
ARDT
EMN
EMN
Q1 26
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
ARDT
ARDT
EMN
EMN
Q1 26
$6.0B
Q4 25
$1.3B
$6.0B
Q3 25
$1.2B
$5.8B
Q2 25
$1.3B
$5.8B
Q1 25
$1.2B
$5.9B
Q4 24
$5.8B
Q3 24
$1.0B
$5.7B
Q2 24
$739.9M
$5.6B
Total Assets
ARDT
ARDT
EMN
EMN
Q1 26
$14.9B
Q4 25
$5.3B
$14.9B
Q3 25
$5.2B
$15.0B
Q2 25
$5.0B
$15.2B
Q1 25
$4.9B
$15.0B
Q4 24
$15.2B
Q3 24
$4.8B
$15.1B
Q2 24
$4.6B
$14.9B
Debt / Equity
ARDT
ARDT
EMN
EMN
Q1 26
Q4 25
0.84×
Q3 25
0.88×
Q2 25
0.87×
Q1 25
0.93×
Q4 24
Q3 24
1.08×
Q2 24
1.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARDT
ARDT
EMN
EMN
Operating Cash FlowLast quarter
$223.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
4.97×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARDT
ARDT
EMN
EMN
Q1 26
Q4 25
$223.4M
$502.0M
Q3 25
$154.4M
$402.0M
Q2 25
$117.5M
$233.0M
Q1 25
$-24.8M
$-167.0M
Q4 24
$540.0M
Q3 24
$89.7M
$396.0M
Q2 24
$367.0M
Free Cash Flow
ARDT
ARDT
EMN
EMN
Q1 26
Q4 25
$390.0M
Q3 25
$265.0M
Q2 25
$83.0M
Q1 25
$-314.0M
Q4 24
$361.0M
Q3 24
$276.0M
Q2 24
$252.0M
FCF Margin
ARDT
ARDT
EMN
EMN
Q1 26
Q4 25
19.8%
Q3 25
12.0%
Q2 25
3.6%
Q1 25
-13.7%
Q4 24
16.1%
Q3 24
11.2%
Q2 24
10.7%
Capex Intensity
ARDT
ARDT
EMN
EMN
Q1 26
Q4 25
5.7%
Q3 25
6.2%
Q2 25
6.6%
Q1 25
6.4%
Q4 24
8.0%
Q3 24
4.9%
Q2 24
4.9%
Cash Conversion
ARDT
ARDT
EMN
EMN
Q1 26
Q4 25
4.97×
4.78×
Q3 25
8.55×
Q2 25
1.61×
1.66×
Q1 25
-0.60×
-0.92×
Q4 24
1.64×
Q3 24
3.41×
2.20×
Q2 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons